查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1923039

伊塞顆粒劑市場按產品配方、劑量強度、適應症類別、最終用戶和分銷管道分類－2026-2032年全球預測

Yiqing Keli Market by Product Formulation, Dosage Strength, Indication Category, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年 Issei 顆粒劑市場規模為 1.0215 億美元，預計到 2026 年將成長至 1.104 億美元，到 2032 年將達到 1.6528 億美元，複合年成長率為 7.11%。

關鍵市場統計數據
基準年 2025 1.0215億美元
預計年份：2026年 1.104億美元
預測年份 2032 1.6528億美元
複合年成長率 (%) 7.11%

該研究以簡潔的策略敘述形式進行了總結，為高階主管提供了確定優先事項和有效分配資源所需的關鍵見解。

本執行摘要綜合了關鍵的策略和營運洞察，旨在為經營團隊、產品團隊和商業職能部門提供明智的決策支援。它整合了觀察到的行業趨勢、結構性變化和實際影響，幫助讀者加快關鍵業務領域的專案優先排序、資源分配和價值實現速度。此分析著重於可操作性的清晰闡述；它並非詳盡的清單，而是重點關注最有可能在中短期內影響競爭地位的趨勢和轉折點。

了解技術、監管和地緣政治重組的整合動態，這些動態正在推動競爭、韌性和創新的持久變革。

市場格局正經歷著一場由多種因素共同驅動的變革：技術應用、不斷演變的監管環境以及不斷變化的客戶期望，這些因素正在重塑競爭格局。數位化的加速正推動解決方案從點解決方案轉型為平台。雲端原生架構和API優先模式能夠實現更快的產品迭代和更強大的生態系統整合。同時，人工智慧和進階分析技術正從實驗性試點走向成熟，成為流程自動化、風險管理和客戶體驗最佳化等關鍵要素，從而提高了差異化和營運韌性的標準。

評估2025年關稅調整對籌資策略、供應鏈設計和採購實務的影響，並考慮其連鎖營運後果。

美國於2025年實施的一系列關稅措施的累積影響已波及供應鏈、籌資策略和成本轉嫁動態，對企業的營運和策略產生了多方面的影響。首先，採購團隊被迫重新評估採購決策，以平衡成本、前置作業時間和供應商集中度風險，許多企業正在加速採購多元化或探索其他地理以降低風險。這導致企業更加關注總到岸成本分析而非基本單位成本，並迫使採購和財務負責人將情境規劃和壓力測試納入供應商選擇流程。

透過細緻的細分洞察，制定有針對性的策略行動，使產品設計、定價和通路策略與買家的獨特需求和實施偏好保持一致。

細分市場層面的清晰認知使領導者能夠根據特定買家的行為和技術需求，客製化市場推廣策略和產品設計決策。透過按應用程式、部署類型和使用案例進行分析，可以揭示指南優先順序排序的模式。例如，面向銀行和金融服務的專用解決方案需要嚴格的安全性和合規性功能；醫療保健部署優先考慮互通性和患者資料保護；製造業強調確定性效能和與操作技術堆疊的整合；而電子商務零售則需要可擴展性和低延遲交易處理。這些特定於應用的需求塑造了產品藍圖，並決定了哪些整合投資能帶來最大的回報。

繪製美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和合作夥伴生態系統圖，以協助制定差異化的打入市場策略和合規策略。

區域差異持續影響需求模式、合作夥伴生態系統和監管風險，因此美洲、歐洲、中東和非洲以及亞太地區需要採取差異化的策略。在美洲，成熟的採購週期和成熟的供應商生態系統有利於規模較大的企業以及能夠展現出可衡量的效率和合規優勢的解決方案。北美企業通常率先採用雲端優先策略，同時密切關注資料居住和隱私框架。同時，在拉丁美洲市場，商業和金融服務的數位化帶來了成長機遇，但也需要企業適應當地的支付系統和分銷模式。

透過整合解決方案、合作夥伴賦能和服務主導成長來評估競爭差異化優勢，從而影響客戶獲取和保留。

該領域的競爭格局呈現出平台整合、選擇性夥伴關係以及對服務能力進行定向投資的多元化特徵。市場領導正積極推廣整合解決方案，將核心產品功能與專業服務結​​合，以加速部署並提升產品生命週期價值。同時，敏捷的新興企業則憑藉其領域專長和創新的定價及部署模式，成功贏得特定垂直市場的客戶。跨雲端服務供應商、系統整合商和通路網路的策略夥伴關係正變得日益重要，從而能夠在複雜的企業環境中提供更廣泛的分銷和部署支援。

透過實施切實可行的策略性措施和營運轉型，增強產品差異化、通路績效和顧客成果，進而建立強大的競爭優勢。

產業領導者應優先採取一系列策略行動，將洞察轉化為永續的競爭優勢。首先，將產品藍圖與最嚴苛的垂直市場需求相匹配，從而打造可防禦的差異化優勢，並確立高階定位。這需要與領域專家和客戶持續互動，共同打造能夠減少整合摩擦並增強合規性的能力。其次，透過按能力和帳戶類型細分合作夥伴、投資賦能以及製定促進長期合作而非交易協議的通用成功指標，最佳化通路策略。第三，採用能反映不同買家偏好的彈性定價結構。訂閱和按使用量付費相結合的方式，既能擴大目標市場，又能維持穩定的收入來源。

本執行摘要詳細介紹了一個混合方法研究框架，該框架結合了主要訪談、次要分析和交叉檢驗綜合，以產生可操作和可靠的研究結果。

本執行摘要的研究結合了定性和定量方法，以確保其穩健性和實用性。主要研究包括對行業高管、採購人員和系統整合商進行結構化訪談，以收集關於採用促進因素、實施難點和供應商選擇標準的第一手資訊。次要研究整合了公開文件、監管指南、技術白皮書和案例研究，以驗證論點並提供更深入的背景資訊。資料整合強調跨資訊來源的交叉檢驗，以減少單一資訊來源偏差，並突出趨同徵兆而非孤立的個案。

總結關鍵策略重點，將研究成果轉化為具體行動，以增強韌性、實現差異化並創造長期價值。

本執行摘要提出的全面觀點明確指出，在動態互聯的市場中運作的企業必須滿足幾個關鍵要求。首先，企業必須在產品、供應鏈和商業模式中建立韌性和敏捷性，以應對關稅波動、地緣政治不確定性和加速的技術變革。其次，以客戶為中心、基於垂直整合的功能、安全性和結果導向服務的差異化策略，能夠打造具有競爭力的價值提案，從而支撐高定價和高客戶維繫。第三，通路和策略夥伴需要有針對性的投資和支持，以將生態系統關係轉化為穩定的收入來源和執行能力。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 伊勢顆粒劑市場依產品配方分類

  • 標準顆粒
    • 糖衣顆粒
    • 無糖顆粒
  • 兒童顆粒劑
    • 低劑量兒童顆粒劑
    • 標準兒童顆粒
  • 膠囊
    • 硬膠囊
    • 軟膠囊
  • 口服液
    • 可飲用溶液
    • 濃縮液

9. 一政顆粒劑市場（以劑量強度分類）

  • 低強度
  • 標準強度
  • 高強度
  • 滴定劑量包

第10章 伊塞顆粒劑市場依適應症分類

  • 上呼吸道感染疾病
    • 寒冷的
    • 急性咽頭炎
    • 急性扁桃腺炎
  • 類流感疾病
    • 季節性流感
    • 病毒性發熱
  • 下呼吸道併發症
    • 急性支氣管炎
    • 慢性支氣管炎急性發作
  • 預防性使用
    • 免疫支持
    • 暴露後預防

第11章 伊勢顆粒劑市場（以最終用戶分類）

  • 醫院
  • 診所
    • 一般診所
    • 耳鼻喉科診所
    • 中醫診所
  • 家用

第12章 宜清顆粒市場（依通路分類）

  • 醫院藥房
  • 零售藥房
  • 中醫診所
  • 網路藥房

第13章 各地區伊勢顆粒市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 伊勢顆粒市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國一成顆粒劑市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 美國宜清顆粒市場

第17章 中國宜清顆粒市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Anguo Yadong Biopharmaceutical Co., Ltd.
  • Guangdong Luofushan National Pharmaceutical Co., Ltd.
  • Guizhou Hengba Pharmaceutical Co., Ltd.
  • Jiangxi Huiren Pharmaceutical Co., Ltd.
  • Jiangxi Xinglin Baima Pharmaceutical Co., Ltd.
  • Jilin Gaomiao Pharmaceutical Co., Ltd.
  • Mengyang Pharmaceutical Co., Ltd.
  • Qionglai Tianyin Pharmaceutical Co., Ltd.
  • Shanxi Jinxin Shuanghe Pharmaceutical Co., Ltd.
  • Tonghua Hongbao Pharmaceutical Co., Ltd.
  • Tonghua Jinkaiwei Pharmaceutical Co., Ltd.
  • Tonghua Jinma Pharmaceutical Group Co., Ltd.
  • Yunnan Xitao Green Pharmaceutical Co., Ltd.
  • Zhejiang Weikang Pharmaceutical Co., Ltd.
Product Code: MRR-867BED9A9EE6

The Yiqing Keli Market was valued at USD 102.15 million in 2025 and is projected to grow to USD 110.40 million in 2026, with a CAGR of 7.11%, reaching USD 165.28 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 102.15 million
Estimated Year [2026] USD 110.40 million
Forecast Year [2032] USD 165.28 million
CAGR (%) 7.11%

Framing the research into a concise strategic narrative that equips senior leaders with the essential insights needed to prioritize initiatives and allocate resources effectively

This executive summary consolidates critical strategic and operational insights to support informed decision-making across senior leadership, product teams, and commercial functions. It synthesizes observed industry dynamics, structural shifts, and practical implications so that readers can prioritize initiatives, allocate resources, and accelerate time-to-value across core business lines. The analysis emphasizes actionable clarity: rather than exhaustive enumeration, it highlights the trends and inflection points most likely to influence competitive positioning over the near to medium term.

The objective is to provide a compact, analytically rigorous narrative that bridges research findings with pragmatic next steps. Throughout the summary, evidence is used to illustrate causal relationships between macro drivers and enterprise outcomes, and transitional language is applied to ensure a logical progression from context to implications and recommendations. Decision-makers will find this resource useful as both a briefing document for stakeholder alignment and a reference for developing strategic responses to fast-evolving external conditions.

Understanding the convergent forces of technology, regulation, and geopolitical realignment that are driving durable shifts in competition, resilience, and innovation

Market landscapes are undergoing transformative shifts driven by technology adoption, regulatory evolution, and changing customer expectations, each interacting to reshape the competitive environment. Digital acceleration is moving beyond point solutions and toward platformization, as cloud-native architectures and API-first models enable faster product iteration and tighter ecosystem integration. Concurrently, artificial intelligence and advanced analytics are maturing from experimental pilots to mission-critical components in process automation, risk management, and customer experience optimization, thereby raising the bar for differentiation and operational resilience.

Regulatory and compliance regimes are converging with data protection imperatives, prompting greater investment in governance, privacy engineering, and auditability. This creates both a compliance burden and a market opportunity for vendors that can embed demonstrable controls into their solutions. Geopolitical dynamics and supply-chain recalibration are incentivizing diversification of sourcing strategies and investment in resilience, which in turn influence cost structures and strategic partnerships. As a result, organizations must rethink vendor selection criteria to include geopolitical risk assessments, service continuity guarantees, and transparent procurement pathways. Finally, the talent landscape is shifting in response to these changes, with cross-functional capabilities that combine domain knowledge, data fluency, and security expertise becoming essential for sustained innovation and risk mitigation.

Assessing how 2025 tariff adjustments have reshaped sourcing strategies, supply chain design, and procurement practices with cascading operational consequences

The cumulative impact of recent tariff measures implemented by the United States in 2025 has propagated through supply chains, procurement strategies, and cost pass-through dynamics, producing several operational and strategic effects for firms. First, procurement teams have had to reassess sourcing decisions to balance cost, lead times, and supplier concentration risk, with many organizations accelerating diversification efforts or exploring alternative geographies to mitigate exposure. This has increased focus on total landed cost analysis rather than base unit pricing, pushing procurement and finance leaders to integrate scenario planning and stress testing into vendor selection.

Second, the tariffs have intensified conversations about nearshoring and regional manufacturing capacity, prompting some firms to evaluate the trade-offs between higher local labor and facility costs and the advantages of reduced transit times, lower inventory buffers, and improved supply-chain visibility. In parallel, affected companies have increased attention to product architecture and bill-of-materials optimization to identify components that present the highest tariff sensitivity and to redesign for modularity or substitution where feasible. Finally, compliance and customs functions have scaled up capabilities to manage classification, valuation, and duty optimization, while finance teams have worked to determine appropriate customer communication strategies around potential price adjustments and to preserve margins without undermining demand.

Deriving targeted strategic actions from granular segmentation insights that align product design, pricing, and channel strategies with distinct buyer needs and deployment preferences

Segment-level clarity enables leaders to tailor go-to-market approaches and product design decisions to specific buyer behaviors and technical requirements. When analyzed by application, deployment, and use case, patterns emerge that inform prioritization: for example, solutions tailored for banking and financial services demand stringent security and compliance features, whereas healthcare implementations prioritize interoperability and patient data safeguards, manufacturing emphasizes deterministic performance and integration with operational technology stacks, and retail ecommerce requires scalability and low-latency transaction processing. These application-specific requirements shape product roadmaps and determine which integration investments yield the highest return.

Enterprise size and end-user classifications further nuance positioning decisions, as the needs of large enterprises diverge from those of medium and small firms in procurement cycles, customization expectations, and purchasing authority. Large organizations typically seek enterprise-grade SLAs, extensive professional services, and complex integration plans, while medium and small enterprises often prioritize ease of deployment, cost predictability, and rapid time-to-value. Deployment mode choices also influence adoption pathways: cloud, hybrid, and on-premise options respond to different risk appetites and operational constraints, and within cloud environments the distinction between private and public architectures affects governance models and total cost considerations. Sales channel economics are equally important; channel partners, including distributors, system integrators, and value added resellers, play a decisive role in market reach and implementation success, whereas direct sales and online channels can drive higher margin but require stronger brand trust and self-service capabilities. Pricing models-perpetual license, subscription, and usage-based-should align with buyer cash-flow preferences and expected consumption patterns, with hybrid pricing often appropriate for mixed-use scenarios. Finally, component-level segmentation across hardware, services, and software highlights the importance of services subcategories such as consulting, integration, and maintenance and support, since these offerings frequently determine post-sale satisfaction and long-term retention rates.

Mapping regional dynamics and partner ecosystems across the Americas, Europe Middle East & Africa, and Asia-Pacific to inform differentiated go-to-market and compliance strategies

Regional variation continues to shape demand patterns, partner ecosystems, and regulatory exposure, requiring differentiated strategies across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established procurement cycles and mature vendor ecosystems favor scale players and solutions that demonstrate measurable efficiency and compliance benefits; North American firms are often early adopters of cloud-first approaches but remain attentive to data residency and privacy frameworks. Meanwhile, Latin American markets present growth opportunities driven by digitalization of commerce and financial services, but they also require adaptations for local payment systems and distribution models.

In Europe, Middle East & Africa, regulatory complexity and diversity of market maturity necessitate localized go-to-market structures and deeper partner collaboration, with data protection regulations and regional trade arrangements influencing deployment and integration decisions. The Middle East is notable for strategic investments in digital infrastructure and sovereign cloud initiatives, which create opportunities for tailored partnerships. Asia-Pacific encompasses both highly sophisticated markets that prioritize cutting-edge automation and emerging markets where cost-sensitive adoption and mobile-first architectures dominate; regional supply-chain roles and manufacturing capacity also make this region central to sourcing and production strategies. Successful regional approaches blend global platform capabilities with local compliance, partner enablement, and go-to-market customization.

Evaluating competitive differentiation driven by integrated solution sets, partner enablement, and service-led growth that influence customer acquisition and retention

Competitive behavior in the sector is characterized by a mix of platform consolidation, selective partnerships, and targeted investments in services capabilities. Market leaders are advancing integrated solution sets that combine core product functionality with professional services to shorten implementation timelines and increase lifetime value. At the same time, nimble challengers are leveraging focused domain expertise or innovative pricing and deployment models to win specific vertical accounts. Strategic partnerships-across cloud providers, systems integrators, and channel networks-are increasingly decisive, since they enable broader distribution and provide implementation muscle in complex enterprise environments.

Organizational differentiation is also increasingly achieved through investments in developer ecosystems, certification programs, and partner enablement that reduce friction for system integrators and value added resellers. Companies that systematically capture implementation knowledge and translate it into reusable assets and preconfigured integrations gain competitive advantage by lowering deployment risk and accelerating customer onboarding. Moreover, firms that invest in transparent security and compliance practices secure trust with large enterprises and regulated industries, thereby unlocking enterprise pipeline opportunities. Finally, leadership in customer success functions-measured through structured onboarding, outcome-based contracts, and ongoing advisory relationships-proves to be a durable moat that supports upsell and retention.

Implement pragmatic strategic moves and operational changes that strengthen product differentiation, channel performance, and customer outcomes to build resilient competitive advantage

Industry leaders should prioritize a set of strategic actions that convert insight into durable advantage: first, align product roadmaps with the most demanding vertical requirements to create defensible differentiation and to justify premium positioning. This requires ongoing engagement with domain experts and customers to co-create features that reduce integration friction and improve compliance posture. Second, optimize channel strategy by segmenting partners by capability and account type, investing in enablement, and developing shared success metrics that incentivize long-term collaboration rather than transactional deals. Third, adopt flexible pricing architectures that reflect diverse buyer preferences: combinations of subscription and usage-based elements can expand addressable markets while preserving predictable revenue streams.

Operationally, leaders should strengthen procurement and supply-chain agility by diversifying supplier bases and accelerating bill-of-materials rationalization to reduce tariff exposure and lead-time vulnerabilities. Complementary investments in governance, privacy engineering, and security-by-design will reduce friction in highly regulated industries and support faster enterprise sales cycles. Finally, build a customer success engine that measures and monetizes outcomes, leveraging playbooks, automated onboarding, and outcome-based service tiers to protect retention and increase lifetime value. These actions, implemented in a staged and cross-functional manner, will position organizations to respond to market volatility while creating enduring competitive barriers.

Detailing a mixed-methods research framework combining primary interviews, secondary analysis, and cross-validated synthesis to produce actionable, reliable insights

The research underpinning this executive summary combined qualitative and quantitative approaches to ensure robustness and practical relevance. Primary research included structured interviews with industry executives, procurement leaders, and systems integrators to capture firsthand perspectives on adoption drivers, implementation friction points, and vendor selection criteria. Secondary analysis incorporated public filings, regulatory guidance, technology white papers, and case studies to triangulate claims and to create contextual depth. Data synthesis emphasized cross-validation across sources to reduce single-source bias and to highlight convergent signals rather than isolated anecdotes.

Analytical methods included thematic coding of qualitative input, comparative scenario analysis to assess strategic options, and value-chain mapping to identify where cost and risk concentrations exist. Segmentation decisions were driven by buyer behavior, deployment patterns, and typical procurement workflows, and the methodology deliberately distinguished between enterprise size, deployment mode, application needs, pricing models, sales channels, and component-level economics. Limitations of the approach are acknowledged: while the research captures prevailing dynamics and directional impacts, granular financial metrics and proprietary customer-level data fall outside the scope of this summary. Accordingly, the findings are intended to guide strategic prioritization and hypothesis formation rather than to serve as a definitive financial forecast.

Summarizing the essential strategic priorities that convert research findings into concrete actions for building resilience, differentiation, and long-term value

The cumulative narrative presented in this executive summary points to several clear imperatives for organizations operating in dynamic and interconnected markets. First, resilience and agility must be engineered into product, supply chain, and commercial models to withstand tariff shifts, geopolitical uncertainty, and accelerating technological change. Second, customer-centric differentiation-anchored in verticalized functionality, security, and outcome-based services-creates defensible value propositions that support premium pricing and higher retention. Third, channel and partner strategies require curated investments and enablement to convert ecosystem relationships into reliable revenue and implementation capacity.

In closing, the most successful organizations will be those that translate strategic intent into operational capabilities: they will prioritize investments that reduce time-to-value for customers, diversify supply and vendor exposure to minimize single points of failure, and enhance governance and compliance to lower adoption friction in regulated industries. By focusing on these priorities with disciplined execution, leaders can transform uncertainty into opportunity and sustain competitive advantage through both incremental optimization and targeted innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Yiqing Keli Market, by Product Formulation

  • 8.1. Standard Granule
    • 8.1.1. Sugar-Coated Granule
    • 8.1.2. Sugar-Free Granule
  • 8.2. Pediatric Granule
    • 8.2.1. Low-Dose Pediatric Granule
    • 8.2.2. Standard Pediatric Granule
  • 8.3. Capsule
    • 8.3.1. Hard Capsule
    • 8.3.2. Soft Capsule
  • 8.4. Oral Solution
    • 8.4.1. Ready-to-Drink Solution
    • 8.4.2. Concentrated Solution

9. Yiqing Keli Market, by Dosage Strength

  • 9.1. Low Strength
  • 9.2. Standard Strength
  • 9.3. High Strength
  • 9.4. Titrated Dose Packs

10. Yiqing Keli Market, by Indication Category

  • 10.1. Upper Respiratory Tract Infection
    • 10.1.1. Common Cold
    • 10.1.2. Acute Pharyngitis
    • 10.1.3. Acute Tonsillitis
  • 10.2. Influenza-Like Illness
    • 10.2.1. Seasonal Influenza
    • 10.2.2. Viral Fever
  • 10.3. Lower Respiratory Complications
    • 10.3.1. Acute Bronchitis
    • 10.3.2. Exacerbation of Chronic Bronchitis
  • 10.4. Preventive Use
    • 10.4.1. Immunity Support
    • 10.4.2. Post-Exposure Prophylaxis

11. Yiqing Keli Market, by End User

  • 11.1. Hospitals
  • 11.2. Clinics
    • 11.2.1. General Practitioner Clinics
    • 11.2.2. ENT Clinics
    • 11.2.3. TCM Clinics
  • 11.3. Home Use

12. Yiqing Keli Market, by Distribution Channel

  • 12.1. Hospital Pharmacies
  • 12.2. Retail Pharmacies
  • 12.3. Traditional Medicine Clinics
  • 12.4. Online Pharmacies

13. Yiqing Keli Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Yiqing Keli Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Yiqing Keli Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Yiqing Keli Market

17. China Yiqing Keli Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Anguo Yadong Biopharmaceutical Co., Ltd.
  • 18.6. Guangdong Luofushan National Pharmaceutical Co., Ltd.
  • 18.7. Guizhou Hengba Pharmaceutical Co., Ltd.
  • 18.8. Jiangxi Huiren Pharmaceutical Co., Ltd.
  • 18.9. Jiangxi Xinglin Baima Pharmaceutical Co., Ltd.
  • 18.10. Jilin Gaomiao Pharmaceutical Co., Ltd.
  • 18.11. Mengyang Pharmaceutical Co., Ltd.
  • 18.12. Qionglai Tianyin Pharmaceutical Co., Ltd.
  • 18.13. Shanxi Jinxin Shuanghe Pharmaceutical Co., Ltd.
  • 18.14. Tonghua Hongbao Pharmaceutical Co., Ltd.
  • 18.15. Tonghua Jinkaiwei Pharmaceutical Co., Ltd.
  • 18.16. Tonghua Jinma Pharmaceutical Group Co., Ltd.
  • 18.17. Yunnan Xitao Green Pharmaceutical Co., Ltd.
  • 18.18. Zhejiang Weikang Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL YIQING KELI MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL YIQING KELI MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL YIQING KELI MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL YIQING KELI MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL YIQING KELI MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL YIQING KELI MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-COATED GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-COATED GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-COATED GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-FREE GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-FREE GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL YIQING KELI MARKET SIZE, BY SUGAR-FREE GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL YIQING KELI MARKET SIZE, BY LOW-DOSE PEDIATRIC GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL YIQING KELI MARKET SIZE, BY LOW-DOSE PEDIATRIC GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL YIQING KELI MARKET SIZE, BY LOW-DOSE PEDIATRIC GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD PEDIATRIC GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD PEDIATRIC GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD PEDIATRIC GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL YIQING KELI MARKET SIZE, BY HARD CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL YIQING KELI MARKET SIZE, BY HARD CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL YIQING KELI MARKET SIZE, BY HARD CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL YIQING KELI MARKET SIZE, BY SOFT CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL YIQING KELI MARKET SIZE, BY SOFT CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL YIQING KELI MARKET SIZE, BY SOFT CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL YIQING KELI MARKET SIZE, BY READY-TO-DRINK SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL YIQING KELI MARKET SIZE, BY READY-TO-DRINK SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL YIQING KELI MARKET SIZE, BY READY-TO-DRINK SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL YIQING KELI MARKET SIZE, BY CONCENTRATED SOLUTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL YIQING KELI MARKET SIZE, BY CONCENTRATED SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL YIQING KELI MARKET SIZE, BY CONCENTRATED SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL YIQING KELI MARKET SIZE, BY LOW STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL YIQING KELI MARKET SIZE, BY LOW STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL YIQING KELI MARKET SIZE, BY LOW STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL YIQING KELI MARKET SIZE, BY STANDARD STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL YIQING KELI MARKET SIZE, BY HIGH STRENGTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL YIQING KELI MARKET SIZE, BY HIGH STRENGTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL YIQING KELI MARKET SIZE, BY HIGH STRENGTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL YIQING KELI MARKET SIZE, BY TITRATED DOSE PACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL YIQING KELI MARKET SIZE, BY TITRATED DOSE PACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL YIQING KELI MARKET SIZE, BY TITRATED DOSE PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL YIQING KELI MARKET SIZE, BY COMMON COLD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL YIQING KELI MARKET SIZE, BY COMMON COLD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL YIQING KELI MARKET SIZE, BY COMMON COLD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE PHARYNGITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE PHARYNGITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE PHARYNGITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE TONSILLITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE TONSILLITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE TONSILLITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL YIQING KELI MARKET SIZE, BY SEASONAL INFLUENZA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL YIQING KELI MARKET SIZE, BY SEASONAL INFLUENZA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL YIQING KELI MARKET SIZE, BY SEASONAL INFLUENZA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL YIQING KELI MARKET SIZE, BY VIRAL FEVER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL YIQING KELI MARKET SIZE, BY VIRAL FEVER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL YIQING KELI MARKET SIZE, BY VIRAL FEVER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE BRONCHITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE BRONCHITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL YIQING KELI MARKET SIZE, BY ACUTE BRONCHITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL YIQING KELI MARKET SIZE, BY EXACERBATION OF CHRONIC BRONCHITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL YIQING KELI MARKET SIZE, BY EXACERBATION OF CHRONIC BRONCHITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL YIQING KELI MARKET SIZE, BY EXACERBATION OF CHRONIC BRONCHITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL YIQING KELI MARKET SIZE, BY IMMUNITY SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL YIQING KELI MARKET SIZE, BY IMMUNITY SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL YIQING KELI MARKET SIZE, BY IMMUNITY SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL YIQING KELI MARKET SIZE, BY POST-EXPOSURE PROPHYLAXIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL YIQING KELI MARKET SIZE, BY POST-EXPOSURE PROPHYLAXIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL YIQING KELI MARKET SIZE, BY POST-EXPOSURE PROPHYLAXIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL YIQING KELI MARKET SIZE, BY GENERAL PRACTITIONER CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL YIQING KELI MARKET SIZE, BY GENERAL PRACTITIONER CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL YIQING KELI MARKET SIZE, BY GENERAL PRACTITIONER CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL YIQING KELI MARKET SIZE, BY ENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL YIQING KELI MARKET SIZE, BY ENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL YIQING KELI MARKET SIZE, BY ENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL YIQING KELI MARKET SIZE, BY TCM CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL YIQING KELI MARKET SIZE, BY TCM CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL YIQING KELI MARKET SIZE, BY TCM CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL YIQING KELI MARKET SIZE, BY HOME USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL YIQING KELI MARKET SIZE, BY HOME USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL YIQING KELI MARKET SIZE, BY HOME USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL YIQING KELI MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL YIQING KELI MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL YIQING KELI MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL YIQING KELI MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL YIQING KELI MARKET SIZE, BY TRADITIONAL MEDICINE CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL YIQING KELI MARKET SIZE, BY TRADITIONAL MEDICINE CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL YIQING KELI MARKET SIZE, BY TRADITIONAL MEDICINE CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL YIQING KELI MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL YIQING KELI MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL YIQING KELI MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL YIQING KELI MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS YIQING KELI MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 137. AMERICAS YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 138. AMERICAS YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 139. AMERICAS YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 140. AMERICAS YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 141. AMERICAS YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 142. AMERICAS YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 143. AMERICAS YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 144. AMERICAS YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 145. AMERICAS YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 146. AMERICAS YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. AMERICAS YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 148. AMERICAS YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE, MIDDLE EAST & AFRICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL YIQING KELI MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 261. ASEAN YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 262. ASEAN YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 263. ASEAN YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 264. ASEAN YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 265. ASEAN YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 266. ASEAN YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 267. ASEAN YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. ASEAN YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 269. ASEAN YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 270. GCC YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 271. GCC YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 272. GCC YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 273. GCC YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 274. GCC YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 275. GCC YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 276. GCC YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 277. GCC YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 278. GCC YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 279. GCC YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 280. GCC YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 281. GCC YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 282. GCC YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. GCC YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 284. GCC YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 293. EUROPEAN UNION YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 294. EUROPEAN UNION YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 295. EUROPEAN UNION YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 296. EUROPEAN UNION YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 297. EUROPEAN UNION YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. EUROPEAN UNION YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 299. EUROPEAN UNION YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 311. BRICS YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 312. BRICS YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. BRICS YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 314. BRICS YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 315. G7 YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 316. G7 YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 317. G7 YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 318. G7 YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 319. G7 YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 320. G7 YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 321. G7 YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 322. G7 YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 323. G7 YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 324. G7 YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 325. G7 YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 326. G7 YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 327. G7 YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. G7 YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 329. G7 YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 330. NATO YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 331. NATO YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 332. NATO YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-2032 (USD MILLION)
  • TABLE 333. NATO YIQING KELI MARKET SIZE, BY PEDIATRIC GRANULE, 2018-2032 (USD MILLION)
  • TABLE 334. NATO YIQING KELI MARKET SIZE, BY CAPSULE, 2018-2032 (USD MILLION)
  • TABLE 335. NATO YIQING KELI MARKET SIZE, BY ORAL SOLUTION, 2018-2032 (USD MILLION)
  • TABLE 336. NATO YIQING KELI MARKET SIZE, BY DOSAGE STRENGTH, 2018-2032 (USD MILLION)
  • TABLE 337. NATO YIQING KELI MARKET SIZE, BY INDICATION CATEGORY, 2018-2032 (USD MILLION)
  • TABLE 338. NATO YIQING KELI MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, 2018-2032 (USD MILLION)
  • TABLE 339. NATO YIQING KELI MARKET SIZE, BY INFLUENZA-LIKE ILLNESS, 2018-2032 (USD MILLION)
  • TABLE 340. NATO YIQING KELI MARKET SIZE, BY LOWER RESPIRATORY COMPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 341. NATO YIQING KELI MARKET SIZE, BY PREVENTIVE USE, 2018-2032 (USD MILLION)
  • TABLE 342. NATO YIQING KELI MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 343. NATO YIQING KELI MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 344. NATO YIQING KELI MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 345. GLOBAL YIQING KELI MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 346. UNITED STATES YIQING KELI MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 347. UNITED STATES YIQING KELI MARKET SIZE, BY PRODUCT FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 348. UNITED STATES YIQING KELI MARKET SIZE, BY STANDARD GRANULE, 2018-20